HomeNewsTrendsHealthBA.2.2 sub-variant sparks fresh COVID-19 concerns but scientists allay fears

BA.2.2 sub-variant sparks fresh COVID-19 concerns but scientists allay fears

In January this year, Omicron was found in over 95 percent samples subjected to whole genome sequencing from across the country of which BA.2 was the most dominant sub-lineage detected in samples, followed by BA.1

March 14, 2022 / 17:19 IST
Story continues below Advertisement
Jilin province in China's northeast recorded over 1,000 new cases for the second day in a row on Monday. (Representative image)
Jilin province in China's northeast recorded over 1,000 new cases for the second day in a row on Monday. (Representative image)

The latest news from China that the business centre of Shenzhen, Jilin province has been put under a strict lockdown in the wake of a fresh spurt in COVID-19 cases has raised fresh worries internationally.

But scientists with the Indian government’s coronavirus genomic surveillance programme, INSACOG, said that there may not be reason for alarm to go locally, even as the Omicron-triggered third wave has now ebbed.

Story continues below Advertisement

In many parts of the world, including Europe and the US, a fresh surge in COVID-19 cases had been reported over the last few weeks, mainly triggered by the BA.2 sub-lineage of the Omicron variant which was first reported in South Africa in late November last year.

The Omicron variant, the highly transmissible COVID-19 virus variant, has two main sub-lineages, BA.1 and BA.2, of which the latter has been found to be even more contagious.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show